Also trades as: 0QCV.IL (IOB) · $vol 4M · 0QCV.L (LSE) · $vol 4M · 4AB.DE (XETRA) · $vol 0M · ABBV.TO (TSX) · $vol 0M · ABBV.BA (BUE) · $vol 0M · 4AB.DU (DUS) · $vol 0M
ABBV NYSE
AbbVie Inc.
1W: +1.5%
1M: +8.5%
3M: +9.0%
YTD: +26.1%
1Y: +25.7%
3Y: +111.5%
5Y: +209.6%
$286.43
-0.31 (-0.11%)
After Hours: $286.36 (-0.07, -0.03%)
Weekly Expected Move ±3.1%
$268
$277
$286
$295
$304
Credit Risk of going bust: lower than 84% of companies Debt: 12.3% of company value Bonds: $2.06B held by 633 funds, 61 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.59 (down 99.1%), AbbVie Inc. would be worth roughly what it owes.
Total debt $70.82B against a stock market value of $506.79B.
Distance to default 11.01 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $39.58B (short-term plus half of long-term), stock volatility 25.7%; Altman Z 2.71. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.59 (down 99.1%), AbbVie Inc. would be worth roughly what it owes.
Total debt $70.82B against a stock market value of $506.79B.
Distance to default 11.01 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $39.58B (short-term plus half of long-term), stock volatility 25.7%; Altman Z 2.71. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$64B
Revenue
+10.4% YoY
$6B
Net Income
+67.5% YoY
$19B
Free Cash Flow
+4.7% YoY
74.7%
Gross Margin
37.9%
Op. Margin
21.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-206.4%
ROA4.6%
ROIC23.5%
Valuation
P/E80.7
P/B-85.5
EV/EBITDA23.9
Leverage
Debt/Equity-11.93
Current Ratio0.81
Interest Cov.4.6x
Quality Scores
Piotroski F7/9
Altman Z2.43
Beneish M-2.82